PAIN
Volume 139, Issue 2 , Pages 284-292 , 15 October 2008

Stress-evoked opioid release inhibits pain in major depressive disorder

Received 4 January 2008 ,Revised 29 March 2008 ,Accepted 24 April 2008.

References 

  1. Amit Z, Galina ZH. Stress-induced analgesia: adaptive pain suppression. Physiol Rev. 1986;66:1091–1120
  2. Bandura A, O’Leary A, Taylor CB, Gauthier J, Gossard D. Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. J Pers Soc Psychol. 1987;53:563–571
  3. Bandura A, Cioffi D, Taylor B, Brouillard M. Perceived self-efficacy in coping with cognitive stressors and opioid activation. J Pers Social Psychol. 1988;55:479–488
  4. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull. 1996;119:95–110
  5. Bastuerk M, Muhtaroglu S, Karaaslan MF, Oguz A, Simsek A, Reyhancan M. The relationship between basal plasma beta-endorphin levels and the severity of major depressive disorders. Klinik Psikofarmakoloji Buelteni. 2000;10:117–120
  6. Beck AT, Steer RA, Brown GK. Beck depression inventory. 2nd ed.. New York: The Psychological Corporation/Harcourt Brace & Company; 1996;
  7. Bencherif B, Fuchs PN, Sheth R, Dannals RF, Campbell JN, Frost JJ. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain. 2002;99:589–598
  8. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979–986
  9. Bruehl S, McCubbin JA, Harden RN. Theoretical review: altered pain regulatory systems in chronic pain. Neurosci Biobehav Rev. 1999;23:877–890
  10. Buchsbaum MS, Davis GC, Bunney WE. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature. 1977;270:620–622
  11. Crabtree BL. Review of naltrexone, a long-acting opiate antagonist. Clin Pharm. 1984;3:273–280
  12. Darko DF, Risch SC, Gillin JC, Golshan S. Association of beta-endorphin with specific clinical symptoms of depression. Am J Psychiatry. 1992;149:1162–1167
  13. Davis GC, Buchsbaum MS, Bunney WE. Analgesia to painful stimuli in affective illness. Am J Psychiatry. 1979;136:1148–1151
  14. Dickens C, McGowan L, Dale S. Impact of depression on experimental pain perception: a systematic review of the literature with meta-analysis. Psychosom Med. 2003;65:369–375
  15. Dworkin RH, Clark WC, Lipsitz JD. Pain responsivity in major depression and bipolar disorder. Psychiatry Res. 1995;56:173–181
  16. El-Sobky A, Dostrovsky JO, Wall PD. Lack of effect of naloxone on pain perception in humans. Nature. 1976;263:783–784
  17. Fillingim RB, Maixner W. Gender differences in response to noxious stimuli. Pain Forum. 1995;4:209–221
  18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders: clinician version. NY, USA: American Psychiatric Press; 1997;
  19. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13:116–137
  20. Frew AK, Drummond PD. Negative affect, pain and sex: the role of endogenous opioids. Pain. 2007;132(Suppl. 1):S77–S85
  21. Gonzalez JP, Brogden RN. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;35:192–213
  22. Goodwin GM, Austin MP, Curran SM, Ross M, Murray C, Prentice N, et al. The elevation of plasma beta-endorphin levels in major depression. J Affect Disord. 1993;29:281–289
  23. Grevert P, Goldstein A. Endorphins: naloxone fails to alter experimental pain or mood in humans. Science. 1978;199:1093–1095
  24. Henkel V, Bussfeld P, Moller HJ, Hegerl U. Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?. Eur Arch Psychiatry Clin Neurosci. 2002;252:240–249
  25. Imbe H, Iwai-Liao Y, Senba E. Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci. 2006;11:2179–2192
  26. Janssen SA. Negative affect and sensitization to pain. Scand J Psychol. 2002;43:131–137
  27. Janssen SA, Arntz A. Real-life stress and opioid-mediated analgesia in novice parachute jumpers. J Psychophysiol. 2001;15:106–113
  28. Jungkunz G, Engel RR, King UG, Kuss HJ. Endogenous opiates increase pain tolerance after stress in humans. Psychiatry Res. 1983;8:13–18
  29. Keay KA, Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev. 2001;25:669–678
  30. Kennedy SE, Koeppe RA, Young EA, Zubieta JK. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry. 2006;63:1199–1208
  31. Kivioja J, Sjalin M, Lindgren U. Psychiatric morbidity in patients with chronic whiplash-associated disorder. Spine. 2004;29:1235–1239
  32. Kudoh A, Katagai H, Takazawa T. Increased postoperative pain scores in chronic depression patients who take antidepressants. J Clin Anesth. 2002;14:421–425
  33. Lautenbacher S, Roscher S, Strian D, Fassbender K, Krumrey K, Krieg JC. Pain perception in depression: relationships to symptomatology and naloxone-sensitive mechanisms. Psychosom Med. 1994;56:345–352
  34. Lautenbacher S, Spernal J, Schreiber W, Krieg JC. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med. 1999;61:822–827
  35. Liberzon I, Zubieta JK, Fig LM, Phan KL, Koeppe RA, Taylor SF. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci USA. 2002;99:7084–7089
  36. Lovibond SH, Lovibond PH. Depression, anxiety, stress scales. Sydney: Psychology Foundation Monograph; 1995;
  37. Marazziti D, Castrogiovanni P, Rossi A, Rosa C, Ghione S, Di Muro A, et al. Pain threshold is reduced in depression. Int J Neuropsychopharmacol. 1998;1:45–48
  38. Pitman RK, van der Kolk BA, Orr SP, Greenberg MS. Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study. Arch Gen Psychiatry. 1990;47:541–544
  39. Ribeiro SC, Kennedy SE, Smith YR, Stohler CS, Zubieta JK. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1264–1280
  40. Robertson LJ, Hammond GR, Drummond PD. The effect of subcutaneous naloxone on experimentally induced pain. J Pain. 2008;9:79–87
  41. Rodgers RJ, Randall JI. Environmentally induced analgesia: situational factors, mechanisms and significance. In:  Rodgers RJ,  Cooper SJ editor. Endorphins, opiates and behavioural processes. New York: Wiley; 1988;
  42. Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship?. Psychol Bull. 1985;97:18–34
  43. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006;26:5777–5785
  44. Spielberger CD. State-trait anxiety inventory. CA: Consulting Psychologists Press, Inc.; 1983;
  45. von Korff M, LeResche L, Dworkin SF. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain. 1993;55:251–258
  46. Weisenfeld-Hallin Z. Sex differences in pain perception. Gender Med. 2005;2:137–145
  47. Willer JC, Dehen H, Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science. 1981;212:689–691
  48. Willer JC, Ernst M. Somatovegetative changes in stress-induced analgesia in man: an electrophysiological and pharmacological study. Ann NY Acad Sci. 1986;467:256–272
  49. Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE. Opioid regulation of hypothalamic–pituitary–adrenal function in depression. Arch Gen Psychiatry. 1985;42:383–386
  50. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311–315
  51. Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry. 2003;60:1145–1153

PII: S0304-3959(08)00231-5

doi: 10.1016/j.pain.2008.04.022

PAIN
Volume 139, Issue 2 , Pages 284-292 , 15 October 2008

Article Tools

* Image Usage & Resolution